<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Triptan</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Triptan">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Triptan</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Triptans</b> are a family of <a href="Tryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tryptamine" title="Tryptamine">tryptamine</a>-based drugs used as abortive medication in the treatment of migraines and cluster headaches. This drug class was first introduced in the 1990s. While effective at treating individual headaches, they do not provide preventive treatment and are not considered a cure. They are not effective for the treatment of tension–type headache,<span class="mw-ref" id="cite_ref-Mutschler_1-0"><a href="#cite_note-Mutschler-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> except in persons who also experience migraines.<span class="mw-ref" id="cite_ref-Green_2015_2-0"><a href="#cite_note-Green_2015-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> They may be effective in disabling tension–type headaches, which exist on a spectrum of migraine.<span class="mw-ref" id="cite_ref-Green_2015_2-1"><a href="#cite_note-Green_2015-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> Triptans do not relieve other kinds of pain.</p>

<div role="note" class="hatnote navigation-not-searchable">Not to be confused with Tryptan (the trade name of amino acid tryptophan) or the hydrocarbon <a href="Triptane.htm" tppabs="https://ptable.com/wiki/compounds/A/Triptane" title="Triptane">triptane</a> or <a href="5-Hydroxytryptophan.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxitriptan" title="Oxitriptan" class="mw-redirect">Oxitriptan</a>.</div>
<table class="infobox" style="width:22em"><tbody><tr><th colspan="2" style="text-align:center;font-size:125%;font-weight:bold;background-color: 
#ddbbee">Triptans</th></tr><tr><td colspan="2" style="text-align:center"><i>Drug class</i></td></tr><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Sumatriptan.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Sumatriptan.svg.png" data-file-width="640" data-file-height="400" data-file-type="drawing" height="156" width="250"></figure-inline><div>Chemical structure of <a href="Sumatriptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Sumatriptan" title="Sumatriptan">sumatriptan</a>, the prototypical triptan</div></td></tr><tr><th colspan="2" style="text-align:center;background: #e8e8e8;">Class identifiers</th></tr><tr><th scope="row">Use</th><td>Migraine, cluster headache</td></tr><tr><th scope="row">ATC code</th><td>N02CC</td></tr><tr><th scope="row">Biological target</th><td>5-HT<sub>1B</sub> receptor,<br>5-HT<sub>1D</sub> receptor</td></tr><tr><td colspan="2" style="text-align:center;background: #e8e8e8; text-align: center"><a href="javascript:if(confirm('https://www.wikidata.org/wiki/Q423866%20  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.wikidata.org/wiki/Q423866%20'" tppabs="https://www.wikidata.org/wiki/Q423866%20" title="d:Q423866 " class="external">In Wikidata</a></td></tr></tbody></table>

<p>The drugs of this class act as agonists for <a href="Serotonin.htm" tppabs="https://ptable.com/wiki/compounds/A/Serotonin" title="Serotonin">serotonin</a> 5-HT<sub>1B</sub> and 5-HT<sub>1D</sub> receptors at blood vessels and nerve endings in the brain. The first clinically available triptan was <a href="Sumatriptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Sumatriptan" title="Sumatriptan">sumatriptan</a>, which has been marketed since 1991. Triptans have largely replaced <a href="Ergotamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ergotamine" title="Ergotamine">ergotamines</a>, an older class of medications used to relieve migraine and cluster headaches.<span class="mw-ref" id="cite_ref-3"><a href="#cite_note-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></p>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_uses">Medical uses</h2></summary>
    
<table class="wikitable" style="float:right; margin:auto 1em auto 1em;">
<caption>Examples of triptans</caption>
<tbody><tr>
<td><a href="Sumatriptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Sumatriptan" title="Sumatriptan">sumatriptan</a></td><td><a href="Rizatriptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Rizatriptan" title="Rizatriptan">rizatriptan</a></td><td><a href="Naratriptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Naratriptan" title="Naratriptan">naratriptan</a></td></tr>
<tr>
<td><figure-inline><img src="../I/m/Sumatriptan.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Sumatriptan.svg.png" data-file-width="640" data-file-height="400" data-file-type="drawing" height="63" width="100"></figure-inline></td><td><figure-inline><img src="../I/m/Rizatriptan.png" tppabs="https://ptable.com/wiki/compounds/I/m/Rizatriptan.png" data-file-width="2940" data-file-height="1761" data-file-type="bitmap" height="60" width="100"></figure-inline></td><td><figure-inline><img src="../I/m/Naratriptan_structure.png" tppabs="https://ptable.com/wiki/compounds/I/m/Naratriptan_structure.png" data-file-width="553" data-file-height="355" data-file-type="bitmap" height="64" width="100"></figure-inline></td></tr>
<tr>
<td><a href="Eletriptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Eletriptan" title="Eletriptan">eletriptan</a></td><td>donitriptan</td><td><a href="Almotriptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Almotriptan" title="Almotriptan">almotriptan</a></td></tr>
<tr>
<td><figure-inline><img src="../I/m/Eletriptanstructure.png" tppabs="https://ptable.com/wiki/compounds/I/m/Eletriptanstructure.png" data-file-width="664" data-file-height="291" data-file-type="bitmap" height="44" width="100"></figure-inline></td><td><figure-inline><img src="../I/m/Donitriptan.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Donitriptan.svg.png" data-file-width="2115" data-file-height="1020" data-file-type="drawing" height="48" width="100"></figure-inline></td><td><figure-inline><img src="../I/m/Almotripan_structure.png" tppabs="https://ptable.com/wiki/compounds/I/m/Almotripan_structure.png" data-file-width="607" data-file-height="250" data-file-type="bitmap" height="41" width="100"></figure-inline></td></tr>
<tr>
<td><a href="Frovatriptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Frovatriptan" title="Frovatriptan">frovatriptan</a></td><td>avitriptan</td><td><a href="Zolmitriptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Zolmitriptan" title="Zolmitriptan">zolmitriptan</a></td></tr>
<tr>
<td><figure-inline><img src="../I/m/Frovatriptan_structure.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Frovatriptan_structure.svg.png" data-file-width="595" data-file-height="305" data-file-type="drawing" height="51" width="100"></figure-inline></td><td><figure-inline><img src="../I/m/Avitriptan.png" tppabs="https://ptable.com/wiki/compounds/I/m/Avitriptan.png" data-file-width="2490" data-file-height="1254" data-file-type="bitmap" height="50" width="100"></figure-inline></td><td><figure-inline><img src="../I/m/Zolmitriptan.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Zolmitriptan.svg.png" data-file-width="1697" data-file-height="932" data-file-type="drawing" height="55" width="100"></figure-inline></td></tr>
<tr>
<td>LY-334370</td><td><span class="new">GR-46611</span><span class="mw-ref" id="cite_ref-4"><a href="#cite_note-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-5"><a href="#cite_note-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span></td></tr>
<tr>
<td><figure-inline><img src="../I/m/LY334370.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/LY334370.svg.png" data-file-width="720" data-file-height="475" data-file-type="drawing" height="66" width="100"></figure-inline></td><td><figure-inline><img src="../I/m/GR_46611.png" tppabs="https://ptable.com/wiki/compounds/I/m/GR_46611.png" data-file-width="853" data-file-height="336" data-file-type="bitmap" height="39" width="100"></figure-inline></td></tr>
<tr class="mw-empty-elt"></tr>
</tbody></table>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Migraine">Migraine</h3></summary>
    
<p>Triptans are used for the treatment of severe migraine attacks or those that do not respond to NSAIDs<span class="mw-ref" id="cite_ref-pmid17405970_6-0"><a href="#cite_note-pmid17405970-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> or other over-the-counter drugs.<span class="mw-ref" id="cite_ref-pmid11112243_7-0"><a href="#cite_note-pmid11112243-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> Triptans are a mid-line treatment suitable for many migraineurs with typical attacks. They may not work for atypical or unusually severe migraine attacks, transformed migraine, or status (continuous) migrainosus.</p>

<p>Triptans are highly effective, reducing the symptoms or aborting the attack within 30 to 90 minutes in 70–80% of patients.</p>

<p>A test measuring a person's skin sensitivity during a migraine may indicate whether the individual will respond to treatment with triptans.<span class="mw-ref" id="cite_ref-8"><a href="#cite_note-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span>  Triptans are most effective in those with no skin sensitivity; with skin sensitivity, it is best to take triptans within twenty minutes of the headache's onset.</p>

<p>Oral <a href="Rizatriptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Rizatriptan" title="Rizatriptan">rizatriptan</a> and nasal <a href="Zolmitriptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Zolmitriptan" title="Zolmitriptan">zolmitriptan</a> are the most used triptans for migraines in children.<span class="mw-ref" id="cite_ref-9"><a href="#cite_note-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Cluster_headache">Cluster headache</h3></summary>
    
<p>Triptans are effective for the treatment of cluster headache. This has been demonstrated for subcutaneous sumatriptan and intranasal zolmitriptan, the former of which is more effective according to a 2013 Cochrane review. Tablets were not considered appropriate in this review.<span class="mw-ref" id="cite_ref-10"><a href="#cite_note-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Altitude_sickness">Altitude sickness</h3></summary>
    
<p>A single randomized controlled trial found that sumatriptan may be able to prevent altitude sickness.<span class="mw-ref" id="cite_ref-pmid17557349_11-0"><a href="#cite_note-pmid17557349-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Available_forms">Available forms</h3></summary>
    
<p>All marketed triptans are available in oral form; some in form of sublingual tablets.<span class="mw-ref" id="cite_ref-AC_12-0"><a href="#cite_note-AC-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> Sumatriptan and zolmitriptan are also available as nasal sprays.<span class="mw-ref" id="cite_ref-AC_12-1"><a href="#cite_note-AC-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span><span class="mw-ref" id="cite_ref-13"><a href="#cite_note-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> For sumatriptan, a number of other application forms are marketed: suppositories, a subcutaneous injection,<span class="mw-ref" id="cite_ref-AC_12-2"><a href="#cite_note-AC-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> an iontophoretic transdermal patch, which uses low voltage controlled by a pre-programmed microchip to deliver a single dose of sumatriptan through the skin within 30 minutes;<span class="mw-ref" id="cite_ref-:0_14-0"><a href="#cite_note-:0-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> a drug-device combination containing sumatriptan powder that is "breath powered" allowing the user to blow sumatriptan powder in to their nostrils;<span class="mw-ref" id="cite_ref-15"><a href="#cite_note-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span> as well as a needle-free injection system that works with air pressure.<span class="mw-ref" id="cite_ref-Zogenix_16-0"><a href="#cite_note-Zogenix-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Contraindications">Contraindications</h2></summary>
    
<p>All triptans are contraindicated in patients with cardiovascular diseases (coronary spasms, symptomatic coronary artery disease, after a heart attack or stroke, uncontrolled hypertension, Raynaud's disease, peripheral artery disease). Most triptans are also contraindicated during pregnancy and breastfeeding and for patients younger than 18; but sumatriptan and zolmitriptan nasal sprays are also approved for youths over 12.<span class="mw-ref" id="cite_ref-Mutschler_1-1"><a href="#cite_note-Mutschler-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> In spite of expert opinion and evidence to the contrary, the FDA and some other drug governance bodies have stated that monoamine oxidase inhibitors are contraindicated for sumatriptan, zolmitriptan and rizatriptan,<span class="mw-ref" id="cite_ref-Ferrari_17-0"><a href="#cite_note-Ferrari-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span><span class="mw-ref" id="cite_ref-Goodman_18-0"><a href="#cite_note-Goodman-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span> and combination with ergot alkaloids such as <a href="Ergotamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ergotamine" title="Ergotamine">ergotamine</a> for all substances.<span class="mw-ref" id="cite_ref-AC_12-3"><a href="#cite_note-AC-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span></p>

<p>At least two triptans (sumatriptan and rizatriptan) have been listed under the unacceptable medication by the Canadian Blood Services as a potential risk to the recipient; hence, donors are required not to have taken the medication for the last 72 hours.</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Adverse_effects">Adverse effects</h2></summary>
    
<p>Triptans have few side effects if used in correct dosage and frequency. The most common adverse effect is recurrence of migraine. A systematic review found that "rizatriptan 10 mg was the only triptan with a recurrence rate greater than that of placebo".<span class="mw-ref" id="cite_ref-pmid17883520_19-0"><a href="#cite_note-pmid17883520-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span></p>

<p>There is a theoretical risk of coronary spasm in patients with established heart disease, and cardiac events after taking triptans may rarely occur.<span class="mw-ref" id="cite_ref-pmid9827245_20-0"><a href="#cite_note-pmid9827245-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Interactions">Interactions</h2></summary>
    
<p>Combination of triptans with other serotonergic drugs such as ergot alkaloids, monoamine oxidase inhibitors, selective serotonin reuptake inhibitors (SSRIs), serotonin–norepinephrine reuptake inhibitors (SNRIs) or St John's wort has been alleged to induce symptoms of a serotonin syndrome (a syndrome of changes in mental status, autonomic instability, neuromuscular abnormalities, and gastrointestinal symptoms),<span class="mw-ref" id="cite_ref-Mutschler_1-2"><a href="#cite_note-Mutschler-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-AC_12-4"><a href="#cite_note-AC-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> whereas scientific studies indicate there is no potential for life-threatening serotonin syndrome in patients taking triptans and SSRI or SNRIs at the same time, although the FDA has officially stated otherwise.<span class="mw-ref" id="cite_ref-21"><a href="#cite_note-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span><span class="mw-ref" id="cite_ref-22"><a href="#cite_note-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span><span class="mw-ref" id="cite_ref-23"><a href="#cite_note-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span><span class="mw-ref" id="cite_ref-24"><a href="#cite_note-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span><span class="mw-ref" id="cite_ref-25"><a href="#cite_note-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span><span class="mw-ref" id="cite_ref-FDA_ALERT_[7/2006]:_26-0"><a href="#cite_note-FDA_ALERT_[7/2006]:-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span> Combining triptans with ergot alkaloids is contraindicated because of the danger of coronary spasms.<span class="mw-ref" id="cite_ref-AC_12-5"><a href="#cite_note-AC-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span></p>

<p>In a study from Harvard Medical School and the University of Florida College of Medicine involving 47,968 patients and published on 26 February 2018, concomitant use of a selective serotonin reuptake inhibitor or selective norepinephrine reuptake inhibitor for depression with a triptan for migraine did not demonstrate an increased risk of the serotonin syndrome.<span class="mw-ref" id="cite_ref-27"><a href="#cite_note-27" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span></p>

<p>Pharmacokinetic interactions (for example, mediated by CYP liver enzymes or transporter proteins) are different for the individual substances; for most triptans, they are mild to absent. Eletriptan blood plasma levels are increased by strong inhibitors of CYP3A4, and frovatriptan levels by CYP1A2 inhibitors such as <a href="Fluvoxamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluvoxamine" title="Fluvoxamine">fluvoxamine</a>.<span class="mw-ref" id="cite_ref-AC_12-6"><a href="#cite_note-AC-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacology">Pharmacology</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Mechanism_of_action">Mechanism of action</h3></summary>
    

<p>Their action is attributed to their agonist<span class="mw-ref" id="cite_ref-Tepper_28-0"><a href="#cite_note-Tepper-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span> effects on <a href="Serotonin.htm" tppabs="https://ptable.com/wiki/compounds/A/Serotonin" title="Serotonin">serotonin</a> 5<span>‑</span>HT<sub>1B</sub> and 5<span>‑</span>HT<sub>1D</sub> receptors in blood vessels (causing their constriction) and nerve endings in the brain, and subsequent inhibition of pro-inflammatory neuropeptide release, including CGRP and substance P. Triptans are selective agents for 5-HT<sub>1B</sub> and 5-HT<sub>1D</sub><span class="mw-ref" id="cite_ref-Tepper_28-1"><a href="#cite_note-Tepper-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span> and have low or even no affinity for other types of 5-HT receptors.<span class="mw-ref" id="cite_ref-Goodman_18-1"><a href="#cite_note-Goodman-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span></p>

<p>5-HT receptors are classified into seven different families named 5-HT<sub>1</sub> to 5-HT<sub>7</sub>. All receptors are G protein coupled receptors with seven transmembrane domains with the one exception of  5-HT<sub>3</sub> receptor which is a ligand gated ion channel. There is a high homology in the amino acid sequence within each family. Each family couples to the same second messenger systems. Subtypes of 5-HT<sub>1</sub> are the 5-HT<sub>1A</sub>, 5-HT<sub>1B</sub>, 5-HT<sub>1D</sub>, 5-HT<sub>1E</sub> and 5-HT<sub>1F</sub> receptors. All 5-HT<sub>1D</sub> receptors are coupled to inhibition of adenylate cyclase. 5-HT<sub>1B</sub> and 5-HT<sub>1D</sub> receptors have been difficult to distinguish on a pharmacological basis. After cloning two distinct genes for 5-HT<sub>1B</sub> and 5-HT<sub>1D</sub> receptors, a better insight into distribution and expression in different tissues was gained, except in brain tissue where they are overlapping in several areas.<span class="mw-ref" id="cite_ref-Hamel,_E._1999_29-0"><a href="#cite_note-Hamel,_E._1999-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span></p>



<p>Most mammalian species, including humans, have 5-HT<sub>1D</sub> binding sites widely distributed throughout the central nervous system. 5-HT<sub>1D</sub> receptors are found in all areas of the brain but they differ in quantity at each area.<span class="mw-ref" id="cite_ref-Lowther_30-0"><a href="#cite_note-Lowther-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span>
An important initiator of head pain is suggested to be the activation of trigeminovascular afferent nerves which upon activation releases neuropeptides such as CGRP, substance P and neurokinin A. Also they are thought to promote neurogenic inflammatory response important for sensitization of sensory afferents, and also transmission and generation of head pain centrally. 5-HT<sub>1D</sub> has been found responsible for inhibition of neurogenic inflammation upon administration with sumatriptan and other related compounds that act on prejunctional 5-HT<sub>1D</sub> receptors.<span class="mw-ref" id="cite_ref-Hamel,_E._1999_29-1"><a href="#cite_note-Hamel,_E._1999-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span></p>

<p>All triptans, like the older drug <a href="Dihydroergotamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydroergotamine" title="Dihydroergotamine">dihydroergotamine</a>, have agonistic effects on the 5-HT<sub>1D</sub> receptor. Comparison of sumatriptan and dihydroergotamine showed that dihydroergotamine has high affinity and sumatriptan has medium affinity for 5-HT<sub>1D</sub>.<span class="mw-ref" id="cite_ref-Tepper_28-2"><a href="#cite_note-Tepper-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span>  Triptans have at least three modes of action. These antimigraine mechanisms are:</p>

<ol><li>vasoconstriction of pain producing intra cranial extracerebral vessels by a direct effect on vascular smooth muscle. Sumatriptan and rizatriptan have been shown to cause vasoconstriction in the human middle meningeal arteries.</li>
<li>inhibition of vasoactive neuropeptide release by trigeminal terminals innervating intracranial vessels and the dura mater. The trigeminocervical complex has 5-HT<sub>1D</sub> receptors that bind dihydroergotamine and triptans in humans. Rizatriptan has been shown to block dural vasodilation and plasma protein extravation by inhibiting the release of CGRP via activation of receptors on preganglionic trigeminal sensory nerver terminals. Sumatriptan is shown to inhibit potassium stimulated CGRP secretion from cultured trigeminal neurons in dose dependant manner and may also inhibit the release of substance P.</li>
<li>inhibition of nociceptive neurotransmission within the trigeminocervical complex in the brainstem and upper cervical spinal column. Rizatriptan has central trigeminal antinociceptive activity.</li></ol>
<p>Other possibilities of triptans in antimigraine effects are modulation of <a href="Nitric_oxide.htm" tppabs="https://ptable.com/wiki/compounds/A/Nitric_oxide" title="Nitric oxide">nitric oxide</a> dependent signal transduction pathways, nitric oxide scavenging in the brain, and sodium dependent cell metabolic activity.<span class="mw-ref" id="cite_ref-31"><a href="#cite_note-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span><span class="mw-ref" id="cite_ref-Tepper_28-3"><a href="#cite_note-Tepper-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacokinetics">Pharmacokinetics</h3></summary>
    
<p>Triptans have a wide variety of pharmacokinetic properties. Bioavailability is between 14% and 70%, biological half-life (T<sub>1/2</sub>) is between 2 and 26 hours. Their good ability to cross the blood-brain barrier and the rather long half life of some triptans may result in lower frequencies of migraine recurrence.<span class="mw-ref" id="cite_ref-Goodman_18-2"><a href="#cite_note-Goodman-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span><span class="mw-ref" id="cite_ref-Bigal_32-0"><a href="#cite_note-Bigal-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span><span class="mw-ref" id="cite_ref-Armstrong_33-0"><a href="#cite_note-Armstrong-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span><span class="mw-ref" id="cite_ref-Mathew_34-0"><a href="#cite_note-Mathew-34" style="counter-reset: mw-Ref 34;"><span class="mw-reflink-text">[34]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Comparison">Comparison</h3></summary>
    
<table class="wikitable" style="margin: 1em auto 1em auto;">
<caption>Comparative pharmacology of triptans, oral formulations<span class="mw-ref" id="cite_ref-Goodman_18-3"><a href="#cite_note-Goodman-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span><span class="mw-ref" id="cite_ref-Bigal_32-1"><a href="#cite_note-Bigal-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span><span class="mw-ref" id="cite_ref-Armstrong_33-1"><a href="#cite_note-Armstrong-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span><span class="mw-ref" id="cite_ref-Mathew_34-1"><a href="#cite_note-Mathew-34" style="counter-reset: mw-Ref 34;"><span class="mw-reflink-text">[34]</span></a></span></caption>
<tbody><tr>
<th>Drug</th><th>Brand</th><th>Company</th><th>Receptor agonist</th><th>5-HT<sub>1D</sub> affinity<br>(pKI in nM)<span class="mw-ref" id="cite_ref-Deleu_35-0"><a href="#cite_note-Deleu-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span></th><th>Bioavailability (%)</th><th>log D<sub>pH 7.4</sub></th><th>T<sub>max</sub> (h)</th><th>T<sub>1/2</sub> (h)</th><th>Metabolism</th><th>Dose (mg)</th></tr>
<tr>
<td><a href="Sumatriptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Sumatriptan" title="Sumatriptan">Sumatriptan</a></td>
<td align="center">Imitrex</td>
<td align="center">Glaxo Smith Kline</td>
<td align="center">5-HT<sub>1B/D</sub></td>
<td align="center">7.9–8.5</td>
<td align="center">14–17</td>
<td align="center">–1.3</td>
<td align="center">2–2.5</td>
<td align="center">2.5</td>
<td align="center">MAO-A</td>
<td align="center">25 <br> 50 <br> 100</td></tr>
<tr>
<td><a href="Zolmitriptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Zolmitriptan" title="Zolmitriptan">Zolmitriptan</a></td>
<td align="center">Zomig</td>
<td align="center"><a href="javascript:if(confirm('https://www.astrazeneca.com/media-centre/press-releases/2017/astrazeneca-enters-agreement-with-grunenthal-to-divest-rights-to-migraine-treatment-zomig-07062017.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.astrazeneca.com/media-centre/press-releases/2017/astrazeneca-enters-agreement-with-grunenthal-to-divest-rights-to-migraine-treatment-zomig-07062017.html'" tppabs="https://www.astrazeneca.com/media-centre/press-releases/2017/astrazeneca-enters-agreement-with-grunenthal-to-divest-rights-to-migraine-treatment-zomig-07062017.html" class="external text external">Grünenthal</a><span class="mw-ref" id="cite_ref-36"><a href="#cite_note-36" style="counter-reset: mw-Ref 36;"><span class="mw-reflink-text">[36]</span></a></span></td>
<td align="center">5-HT<sub>1B/D</sub></td>
<td align="center">9.2</td>
<td align="center">40</td>
<td align="center">–0.7</td>
<td align="center">1.5–2</td>
<td align="center">2–3</td>
<td align="center">MAO-A <br> CYP1A2</td>
<td align="center">2.5 <br> 5</td></tr>
<tr>
<td><a href="Naratriptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Naratriptan" title="Naratriptan">Naratriptan</a></td>
<td align="center">Amerge</td>
<td align="center">Glaxo Smith Kline</td>
<td align="center">5-HT<sub>1B/D</sub></td>
<td align="center">8.3</td>
<td align="center">70</td>
<td align="center">–0.2</td>
<td align="center">2–3</td>
<td align="center">6</td>
<td align="center">many CYPs <br> MAO-A</td>
<td align="center">1 <br> 2.5</td></tr>
<tr>
<td><a href="Rizatriptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Rizatriptan" title="Rizatriptan">Rizatriptan</a></td>
<td align="center">Maxalt</td>
<td align="center">Merck</td>
<td align="center">5-HT<sub>1B/D</sub></td>
<td align="center">7.7</td>
<td align="center">45</td>
<td align="center">–0.7</td>
<td align="center">1–1.5</td>
<td align="center">2–2.5</td>
<td align="center">MAO-A</td>
<td align="center">5 <br> 10</td></tr>
<tr>
<td><a href="Almotriptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Almotriptan" title="Almotriptan">Almotriptan</a></td>
<td align="center">Axert</td>
<td align="center">Almirall-Prodesfarma</td>
<td align="center">5-HT<sub>1B/D</sub> <br> 5-HT<sub>1F</sub></td>
<td align="center">7.8</td>
<td align="center">70</td>
<td align="center">+0.35</td>
<td align="center">2.5</td>
<td align="center">3.6</td>
<td align="center">CYP2D6 <br> CYP3A4 <br> MAO-A</td>
<td align="center">6.25 <br> 12.5</td></tr>
<tr>
<td><a href="Eletriptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Eletriptan" title="Eletriptan">Eletriptan</a></td>
<td align="center">Relpax</td>
<td align="center">Pfizer</td>
<td align="center">5-HT<sub>1B/D</sub> <br> 5-HT<sub>1F</sub><span class="mw-ref" id="cite_ref-relpax_spc_37-0"><a href="#cite_note-relpax_spc-37" style="counter-reset: mw-Ref 37;"><span class="mw-reflink-text">[37]</span></a></span></td>
<td align="center">8.9</td>
<td align="center">50</td>
<td align="center">+0.5</td>
<td align="center">1–2</td>
<td align="center">3.6–5.5</td>
<td align="center">CYP3A4</td>
<td align="center">20 <br> 40 <br> 80</td></tr>
<tr>
<td><a href="Frovatriptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Frovatriptan" title="Frovatriptan">Frovatriptan</a></td>
<td align="center">Frova</td>
<td align="center">Vernalis</td>
<td align="center">5-HT<sub>1B/D</sub></td>
<td align="center">8.4</td>
<td align="center">24–30</td>
<td align="center"></td>
<td align="center">2–4</td>
<td align="center">26</td>
<td align="center">CYP1A2</td>
<td align="center">2.5</td></tr>
</tbody></table>

<p>Zolmitriptan is different from the other triptans because it is converted to an active N-desmethyl metabolite which has higher affinity for the 5-HT<sub>1D</sub> and 5-HT<sub>1B</sub> receptors; both substances have a biological half-life of 2 to 3 hours.<span class="mw-ref" id="cite_ref-Goodman_18-4"><a href="#cite_note-Goodman-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span> In studies, newer triptans are mostly compared to sumatriptan.<span class="mw-ref" id="cite_ref-Ferrari_17-1"><a href="#cite_note-Ferrari-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span> They are better than sumatriptan for their longer half-life in plasma and higher oral bioavailability,<span class="mw-ref" id="cite_ref-Foyes_38-0"><a href="#cite_note-Foyes-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span> but have a higher potential for central nervous side effects.<span class="mw-ref" id="cite_ref-Mutschler_1-3"><a href="#cite_note-Mutschler-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>

<p>Donitriptan and avitriptan were never marketed.</p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="History">History</h2></summary>
    

<p>The history of triptans began with the proposed existence of then unknown serotonin (5-hydroxytryptamine, 5-HT). In the late 1940s two groups of investigators, one in Italy and the other in the United States, identified a substance that was called <i>serotonin</i> in the US and <i>enteramine</i> in Italy. In the early 1950s it was confirmed that both substances were the same. In the mid-1950s it was proposed that serotonin had a role as a neurotransmitter in the central nervous system (CNS) of animals. Investigations of the mechanism of action were not very successful as experimental techniques were lacking.<span class="mw-ref" id="cite_ref-Foyes_38-1"><a href="#cite_note-Foyes-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span></p>

<p>Later in the 1960s, studies showed that vasoconstriction caused by 5-HT, noradrenaline and <a href="Ergotamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ergotamine" title="Ergotamine">ergotamine</a> could reduce migraine attacks. Patrick P.A. Humphrey among others at Glaxo started researching the 5-HT receptor to discover a more direct 5-HT agonist with fewer side effects.</p>

<p>They continued developing and working on a desirable action on 5-HT by 5-HT<sub>1</sub> receptor activation for an anti-migraine drug. Continued work led to the development of sumatriptan, now known as the first 5-HT<sub>1</sub> agonist, selective for the 5-HT<sub>1D/B</sub> receptors and also the 5-HT<sub>1F</sub> receptor with less affinity. By 1991 sumatriptan became available in clinical use in the Netherlands and in the US in 1993. However, there was always a debate about its mechanism of action, and it still remains unclear today. Later, Mike Moskowitz proposed a theory about "neuronal extravasation", and this was the first clue that sumatriptan might have a direct neuronal effect in migraine attacks.<span class="mw-ref" id="cite_ref-39"><a href="#cite_note-39" style="counter-reset: mw-Ref 39;"><span class="mw-reflink-text">[39]</span></a></span></p>

<p>Sumatriptan became a prototype for other triptans that have been developed for improved selectivity for the 5-HT<sub>1D/B</sub> receptors.<span class="mw-ref" id="cite_ref-Foyes_38-2"><a href="#cite_note-Foyes-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Society_and_culture">Society and culture</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Legal_status">Legal status</h3></summary>
    
<p>These drugs have been available only by prescription (US, Canada and UK), but sumatriptan became available over-the-counter in the UK in June 2006.<span class="mw-ref" id="cite_ref-BBC_generic_40-0"><a href="#cite_note-BBC_generic-40" style="counter-reset: mw-Ref 40;"><span class="mw-reflink-text">[40]</span></a></span> The brand name of the OTC product in the UK is Imigran Recovery. The patent on Imitrex STATDose expired in December 2006, and injectable sumatriptan became available as a generic formula in August 2008. Sumavel Dosepro is a needle-free delivery of injectable sumatriptan that was approved in the US by the FDA in July 2009.<span class="mw-ref" id="cite_ref-Zogenix_16-1"><a href="#cite_note-Zogenix-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span> Sumatriptan became available as a generic in the US in late 2009. It used to be sold over-the-counter in Romania under the Imigran brand; however, as of August 2014 prescription is required. Zecuity, a sumatriptan transdermal patch, was approved by the US FDA in January 2013.<span class="mw-ref" id="cite_ref-:0_14-1"><a href="#cite_note-:0-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> The sumatriptan nasal powder was approved by the FDA in January 2016 and became available in the U.S. May 2016.<span class="mw-ref" id="cite_ref-41"><a href="#cite_note-41" style="counter-reset: mw-Ref 41;"><span class="mw-reflink-text">[41]</span></a></span> Naritriptan is available OTC in Germany and Brazil.</p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<dl><dt>Notes</dt></dl>
<div class="reflist columns references-column-width" style="-moz-column-width: 35em; -webkit-column-width: 35em; column-width: 35em; list-style-type: decimal;">
<ol class="mw-references references"><li id="cite_note-Mutschler-1"> <span id="mw-reference-text-cite_note-Mutschler-1" class="mw-reference-text"><cite id="CITEREFMutschlerGerd_GeisslingerHeyo_K._KroemerSabine_Menzel2013" class="citation book cs1">Mutschler, Ernst; Gerd Geisslinger; Heyo K. Kroemer; Sabine Menzel; Peter Ruth (2013). <i>Arzneimittelwirkungen</i> (in German) (10 ed.). Stuttgart: Wissenschaftliche Verlagsgesellschaft. pp.<span>&nbsp;</span>233–4. ISBN<span>&nbsp;</span><bdi>978-3-8047-2898-1</bdi>.</cite></span></li><li id="cite_note-Green_2015-2"> <span id="mw-reference-text-cite_note-Green_2015-2" class="mw-reference-text"><cite id="CITEREFGreen2015" class="citation book cs1">Green, Mark W. (2015). <a href="javascript:if(confirm('https://books.google.com/books?id=h-acBAAAQBAJ&pg=PA44  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=h-acBAAAQBAJ&pg=PA44'" tppabs="https://books.google.com/books?id=h-acBAAAQBAJ&pg=PA44" class="external text external">"Overview of Migraine: Recognition, Diagnosis, and Pathophysiology"</a>.  In Diamond, Seymour; Cady, Roger K.; Diamond, Merle L.; Green, Mark W.; Martin, Vincent T. (eds.). <i>Headache and Migraine Biology and Management</i>. Academic Press. p.<span>&nbsp;</span>44. ISBN<span>&nbsp;</span><bdi>9780128009017</bdi>. <a href="javascript:if(confirm('https://web.archive.org/web/20180506021431/https://books.google.com/books?id=h-acBAAAQBAJ&pg=PA44  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20180506021431/https://books.google.com/books?id=h-acBAAAQBAJ&pg=PA44'" tppabs="https://web.archive.org/web/20180506021431/https://books.google.com/books?id=h-acBAAAQBAJ&pg=PA44" class="external text external">Archived</a> from the original on 2018-05-06 <span>–</span> via GoogleBooks.</cite></span></li><li id="cite_note-3"> <span id="mw-reference-text-cite_note-3" class="mw-reference-text"><cite id="CITEREFAntonaciGhiottoWuPucci2016" class="citation journal cs1">Antonaci, Fabio; Ghiotto, Natascia; Wu, Shizheng; Pucci, Ennio; Costa, Alfredo (2016). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870579  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870579'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870579" class="external text external">"Recent advances in migraine therapy"</a>. <i>SpringerPlus</i>. <b>5</b>: 637. doi:<a href="javascript:if(confirm('https://doi.org/10.1186%2Fs40064-016-2211-8  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1186%2Fs40064-016-2211-8'" tppabs="https://doi.org/10.1186%2Fs40064-016-2211-8" class="external text external">10.1186/s40064-016-2211-8</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/2193-1801  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/2193-1801'" tppabs="https://www.worldcat.org/issn/2193-1801" class="external text external">2193-1801</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870579  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870579'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870579" class="external text external">4870579</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/27330903  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/27330903'" tppabs="https://pubmed.ncbi.nlm.nih.gov/27330903" class="external text external">27330903</a>.</cite></span></li><li id="cite_note-4"> <span id="mw-reference-text-cite_note-4" class="mw-reference-text"><cite id="CITEREFAmireaultBayardLaunaySibon2013" class="citation journal cs1">Amireault, Pascal; Bayard, Elisa; Launay, Jean-Marie; Sibon, David; Le Van Kim, Caroline; Colin, Yves; Dy, Michel; Hermine, Olivier; Côté, Francine (2013). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866204  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866204'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866204" class="external text external">"Serotonin is a Key Factor for Mouse Red Blood Cell Survival"</a>. <i>PLOS ONE</i>. <b>8</b> (12): e83010. Bibcode:<a href="javascript:if(confirm('https://ui.adsabs.harvard.edu/abs/2013PLoSO...883010A  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://ui.adsabs.harvard.edu/abs/2013PLoSO...883010A'" tppabs="https://ui.adsabs.harvard.edu/abs/2013PLoSO...883010A" class="external text external">2013PLoSO...883010A</a>. doi:<a href="javascript:if(confirm('https://doi.org/10.1371%2Fjournal.pone.0083010  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1371%2Fjournal.pone.0083010'" tppabs="https://doi.org/10.1371%2Fjournal.pone.0083010" class="external text external">10.1371/journal.pone.0083010</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866204  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866204'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866204" class="external text external">3866204</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24358245  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24358245'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24358245" class="external text external">24358245</a>.</cite></span></li><li id="cite_note-5"> <span id="mw-reference-text-cite_note-5" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/gr-46611  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/gr-46611'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/gr-46611" class="external text external">"3-<span>[</span>3-(2-Dimethylaminoethyl)-1H-indol-5-yl<span>]</span>-N-(4-methoxybenzyl)acrylamide"</a>. PubChem<span class="reference-accessdate">. Retrieved <span class="nowrap">2020-06-24</span></span>.</cite></span></li><li id="cite_note-pmid17405970-6"> <span id="mw-reference-text-cite_note-pmid17405970-6" class="mw-reference-text"><cite id="CITEREFBrandesKudrowStark2007" class="citation journal cs1">Brandes JL, Kudrow D, Stark SR,  et al. (2007). <a href="javascript:if(confirm('https://doi.org/10.1001/jama.297.13.1443  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001/jama.297.13.1443'" tppabs="https://doi.org/10.1001/jama.297.13.1443" class="external text external">"Sumatriptan-naproxen for acute treatment of migraine: a randomized trial"</a>. <i>JAMA</i>. <b>297</b> (13): 1443–1454. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1001%2Fjama.297.13.1443  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001%2Fjama.297.13.1443'" tppabs="https://doi.org/10.1001%2Fjama.297.13.1443" class="external text external">10.1001/jama.297.13.1443</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17405970  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17405970'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17405970" class="external text external">17405970</a>.</cite></span></li><li id="cite_note-pmid11112243-7"> <span id="mw-reference-text-cite_note-pmid11112243-7" class="mw-reference-text"><cite id="CITEREFLiptonBaggishStewartCodispoti2000" class="citation journal cs1">Lipton RB, Baggish JS, Stewart WF, Codispoti JR, Fu M (2000). <a href="javascript:if(confirm('https://doi.org/10.1001/archinte.160.22.3486  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001/archinte.160.22.3486'" tppabs="https://doi.org/10.1001/archinte.160.22.3486" class="external text external">"Efficacy and safety of acetaminophen in the treatment of migraine: results of a randomized, double-blind, placebo-controlled, population-based study"</a>. <i>Arch. Intern. Med</i>. <b>160</b> (22): 3486–92. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1001%2Farchinte.160.22.3486  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001%2Farchinte.160.22.3486'" tppabs="https://doi.org/10.1001%2Farchinte.160.22.3486" class="external text external">10.1001/archinte.160.22.3486</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11112243  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11112243'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11112243" class="external text external">11112243</a>.</cite></span></li><li id="cite_note-8"> <span id="mw-reference-text-cite_note-8" class="mw-reference-text"><cite id="CITEREFBursteinCollinsJakubowski2004" class="citation journal cs1">Burstein, R; Collins, B; Jakubowski, M (2004). "Defeating migraine pain with triptans: A race against the development of cutaneous allodynia". <i>Annals of Neurology</i>. <b>55</b> (1): 19–26. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fana.10786  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fana.10786'" tppabs="https://doi.org/10.1002%2Fana.10786" class="external text external">10.1002/ana.10786</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/14705108  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/14705108'" tppabs="https://pubmed.ncbi.nlm.nih.gov/14705108" class="external text external">14705108</a>.</cite></span></li><li id="cite_note-9"> <span id="mw-reference-text-cite_note-9" class="mw-reference-text"><cite id="CITEREFEilandHunt2010" class="citation journal cs1">Eiland, L. S.; Hunt, M. O. (2010). "The use of triptans for pediatric migraines". <i>Paediatr Drugs</i>. <b>12</b> (6): 379–389. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F11532860-000000000-00000  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F11532860-000000000-00000'" tppabs="https://doi.org/10.2165%2F11532860-000000000-00000" class="external text external">10.2165/11532860-000000000-00000</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21028917  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21028917'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21028917" class="external text external">21028917</a>. S2CID<span>&nbsp;</span><a href="javascript:if(confirm('https://api.semanticscholar.org/CorpusID:11187764  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://api.semanticscholar.org/CorpusID:11187764'" tppabs="https://api.semanticscholar.org/CorpusID:11187764" class="external text external">11187764</a>.</cite></span></li><li id="cite_note-10"> <span id="mw-reference-text-cite_note-10" class="mw-reference-text"><cite id="CITEREFLawDerryMoore2013" class="citation journal cs1">Law, S; Derry, S; Moore, R. A. (2013). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170909  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170909'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170909" class="external text external">"Triptans for acute cluster headache"</a>. <i>The Cochrane Database of Systematic Reviews</i>. <b>7</b> (7): CD008042. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F14651858.CD008042.pub3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F14651858.CD008042.pub3'" tppabs="https://doi.org/10.1002%2F14651858.CD008042.pub3" class="external text external">10.1002/14651858.CD008042.pub3</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170909  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170909'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170909" class="external text external">4170909</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24353996  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24353996'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24353996" class="external text external">24353996</a>.</cite></span></li><li id="cite_note-pmid17557349-11"> <span id="mw-reference-text-cite_note-pmid17557349-11" class="mw-reference-text"><cite id="CITEREFJafarianGorouhiSalimiLotfi2007" class="citation journal cs1">Jafarian S, Gorouhi F, Salimi S, Lotfi J (2007). "Sumatriptan for prevention of acute mountain sickness: randomized clinical trial". <i>Ann. Neurol</i>. <b>62</b> (3): 273–7. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fana.21162  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fana.21162'" tppabs="https://doi.org/10.1002%2Fana.21162" class="external text external">10.1002/ana.21162</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17557349  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17557349'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17557349" class="external text external">17557349</a>.</cite></span></li><li id="cite_note-AC-12"> <span id="mw-reference-text-cite_note-AC-12" class="mw-reference-text"><cite id="CITEREFHaberfeld,_H2016" class="citation book cs1">Haberfeld, H, ed. (2016). <i>Austria-Codex</i> (in German). Vienna: Österreichischer Apothekerverlag. Cofact.</cite></span></li><li id="cite_note-13"> <span id="mw-reference-text-cite_note-13" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Imitrex_Nasal_Spray/pdf/IMITREX-NASAL-SPRAY-PI-PIL.PDF  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Imitrex_Nasal_Spray/pdf/IMITREX-NASAL-SPRAY-PI-PIL.PDF'" tppabs="https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Imitrex_Nasal_Spray/pdf/IMITREX-NASAL-SPRAY-PI-PIL.PDF" class="external text external">"Imitrex Nasal Spray package insert"</a> <span class="cs1-format">(PDF)</span>. <i>GlaxoSmithKline prescribing information</i>. <a href="javascript:if(confirm('https://web.archive.org/web/20150905173656/https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Imitrex_Nasal_Spray/pdf/IMITREX-NASAL-SPRAY-PI-PIL.PDF  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20150905173656/https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Imitrex_Nasal_Spray/pdf/IMITREX-NASAL-SPRAY-PI-PIL.PDF'" tppabs="https://web.archive.org/web/20150905173656/https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Imitrex_Nasal_Spray/pdf/IMITREX-NASAL-SPRAY-PI-PIL.PDF" class="external text external">Archived</a> <span class="cs1-format">(PDF)</span> from the original on September 5, 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">May 20,</span> 2016</span>.</cite></span></li><li id="cite_note-:0-14"> <span id="mw-reference-text-cite_note-:0-14" class="mw-reference-text"><cite id="CITEREFPierceMarburyO'NeillSiegel2009" class="citation journal cs1">Pierce, Mark; Marbury, Thomas; O'Neill, Carol; Siegel, Steven; Du, Wei; Sebree, Terri (2009-06-01). "Zelrix: a novel transdermal formulation of sumatriptan". <i>Headache</i>. <b>49</b> (6): 817–825. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1526-4610.2009.01437.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1526-4610.2009.01437.x'" tppabs="https://doi.org/10.1111%2Fj.1526-4610.2009.01437.x" class="external text external">10.1111/j.1526-4610.2009.01437.x</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1526-4610  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1526-4610'" tppabs="https://www.worldcat.org/issn/1526-4610" class="external text external">1526-4610</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19438727  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19438727'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19438727" class="external text external">19438727</a>.</cite></span></li><li id="cite_note-15"> <span id="mw-reference-text-cite_note-15" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.pharmacytimes.com/news/onzetra-xsail-approved-as-migraine-treatment  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.pharmacytimes.com/news/onzetra-xsail-approved-as-migraine-treatment'" tppabs="https://www.pharmacytimes.com/news/onzetra-xsail-approved-as-migraine-treatment" class="external text external">"Onzetra Xsail Approved as Migraine Treatment"</a>. <i>pharmacytimes.com</i>. February 3, 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">October 1,</span> 2019</span>.</cite></span></li><li id="cite_note-Zogenix-16"> <span id="mw-reference-text-cite_note-Zogenix-16" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.zogenix.com/index.php/news/sumavel-dosepro-sumatriptan-injection-approved-by-fda-for-acute-migraine-and-cluster-headache/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.zogenix.com/index.php/news/sumavel-dosepro-sumatriptan-injection-approved-by-fda-for-acute-migraine-and-cluster-headache/'" tppabs="http://www.zogenix.com/index.php/news/sumavel-dosepro-sumatriptan-injection-approved-by-fda-for-acute-migraine-and-cluster-headache/" class="external text external">"Zogenix, Inc. - Therapeutic Solutions for CNS Disorders and Rare Disease"</a>. <i>www.zogenix.com</i>. <a href="javascript:if(confirm('https://web.archive.org/web/20160821125219/http://www.zogenix.com/index.php/news/sumavel-dosepro-sumatriptan-injection-approved-by-fda-for-acute-migraine-and-cluster-headache/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20160821125219/http://www.zogenix.com/index.php/news/sumavel-dosepro-sumatriptan-injection-approved-by-fda-for-acute-migraine-and-cluster-headache/'" tppabs="https://web.archive.org/web/20160821125219/http://www.zogenix.com/index.php/news/sumavel-dosepro-sumatriptan-injection-approved-by-fda-for-acute-migraine-and-cluster-headache/" class="external text external">Archived</a> from the original on 21 August 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">6 May</span> 2018</span>.</cite></span></li><li id="cite_note-Ferrari-17"> <span id="mw-reference-text-cite_note-Ferrari-17" class="mw-reference-text"><cite id="CITEREFFerrariGoadsbyRoonLipton2002" class="citation journal cs1">Ferrari, M. D.; Goadsby, P. J.; Roon, K. I.; Lipton, R. B. (2002). "Triptan (serotonin, 5-HT1D/1B agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials". <i>Cephalalgia</i>. <b>22</b> (8): 633–658. doi:<a href="javascript:if(confirm('https://doi.org/10.1046%2Fj.1468-2982.2002.00404.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1046%2Fj.1468-2982.2002.00404.x'" tppabs="https://doi.org/10.1046%2Fj.1468-2982.2002.00404.x" class="external text external">10.1046/j.1468-2982.2002.00404.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12383060  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12383060'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12383060" class="external text external">12383060</a>.</cite></span></li><li id="cite_note-Goodman-18"> <span id="mw-reference-text-cite_note-Goodman-18" class="mw-reference-text"><cite class="citation book cs1">Brunton, L., Lazo, J., Parker, K. (2006). <i>Goodman &amp; Gilman's The Pharmacological Basis of Therapeutics</i> (11th ed.). McGraw-Hill Education. pp.<span>&nbsp;</span>305–308.</cite><span class="cs1-maint citation-comment">CS1 maint: uses authors parameter (link)</span></span></li><li id="cite_note-pmid17883520-19"> <span id="mw-reference-text-cite_note-pmid17883520-19" class="mw-reference-text"><cite id="CITEREFPascualMateosRoigSanchez-Del-Rio2007" class="citation journal cs1">Pascual J, Mateos V, Roig C, Sanchez-Del-Rio M, Jiménez D (2007). "Marketed oral triptans in the acute treatment of migraine: a systematic review on efficacy and tolerability". <i>Headache</i>. <b>47</b> (8): 1152–68. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1526-4610.2007.00849.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1526-4610.2007.00849.x'" tppabs="https://doi.org/10.1111%2Fj.1526-4610.2007.00849.x" class="external text external">10.1111/j.1526-4610.2007.00849.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17883520  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17883520'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17883520" class="external text external">17883520</a>.</cite></span></li><li id="cite_note-pmid9827245-20"> <span id="mw-reference-text-cite_note-pmid9827245-20" class="mw-reference-text"><cite id="CITEREFDahlöfMathew1998" class="citation journal cs1">Dahlöf CG, Mathew N (1998). "Cardiovascular safety of 5HT1B/1D agonists--is there a cause for concern?". <i>Cephalalgia: An International Journal of Headache</i>. <b>18</b> (8): 539–45. doi:<a href="javascript:if(confirm('https://doi.org/10.1046%2Fj.1468-2982.1998.1808539.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1046%2Fj.1468-2982.1998.1808539.x'" tppabs="https://doi.org/10.1046%2Fj.1468-2982.1998.1808539.x" class="external text external">10.1046/j.1468-2982.1998.1808539.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9827245  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9827245'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9827245" class="external text external">9827245</a>.</cite></span></li><li id="cite_note-21"> <span id="mw-reference-text-cite_note-21" class="mw-reference-text"><cite id="CITEREFShapiroTepper2007" class="citation journal cs1">Shapiro, Robert E.; Tepper, Stewart J. (2007). "The Serotonin Syndrome, Triptans, and the Potential for Drug–Drug Interactions". <i>Headache: The Journal of Head and Face Pain</i>. <b>47</b> (2): 266–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1526-4610.2006.00691.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1526-4610.2006.00691.x'" tppabs="https://doi.org/10.1111%2Fj.1526-4610.2006.00691.x" class="external text external">10.1111/j.1526-4610.2006.00691.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17300366  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17300366'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17300366" class="external text external">17300366</a>.</cite></span></li><li id="cite_note-22"> <span id="mw-reference-text-cite_note-22" class="mw-reference-text"><cite id="CITEREFEvansTepperShapiroSun-Edelstein2010" class="citation journal cs1">Evans, Randolph W.; Tepper, Stewart J.; Shapiro, Robert E.; Sun-Edelstein, Christina; Tietjen, Gretchen E. (2010). "The FDA Alert on Serotonin Syndrome With Use of Triptans Combined With Selective Serotonin Reuptake Inhibitors or Selective Serotonin-Norepinephrine Reuptake Inhibitors: American Headache Society Position Paper". <i>Headache: The Journal of Head and Face Pain</i>. <b>50</b> (6): 1089. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1526-4610.2010.01691.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1526-4610.2010.01691.x'" tppabs="https://doi.org/10.1111%2Fj.1526-4610.2010.01691.x" class="external text external">10.1111/j.1526-4610.2010.01691.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20618823  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20618823'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20618823" class="external text external">20618823</a>.</cite></span></li><li id="cite_note-23"> <span id="mw-reference-text-cite_note-23" class="mw-reference-text"><cite id="CITEREFGillman2010" class="citation journal cs1">Gillman (2010). "Triptans, serotonin agonists, and serotonin syndrome (serotonin toxicity): a review". <i>Headache</i>. <b>50</b> (2): 264–272. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1526-4610.2009.01575.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1526-4610.2009.01575.x'" tppabs="https://doi.org/10.1111%2Fj.1526-4610.2009.01575.x" class="external text external">10.1111/j.1526-4610.2009.01575.x</a>.</cite></span></li><li id="cite_note-24"> <span id="mw-reference-text-cite_note-24" class="mw-reference-text"><cite id="CITEREFEvans2007" class="citation journal cs1">Evans, R. W. (2007). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2100123  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2100123'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2100123" class="external text external">"The FDA alert on serotonin syndrome with combined use of SSRIs or SNRIs and triptans: an analysis of the 29 case reports"</a>. <i>MedGenMed<span>&nbsp;</span>: Medscape General Medicine</i>. <b>9</b> (3): 48. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2100123  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2100123'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2100123" class="external text external">2100123</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18092054  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18092054'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18092054" class="external text external">18092054</a>.</cite></span></li><li id="cite_note-25"> <span id="mw-reference-text-cite_note-25" class="mw-reference-text"><cite id="CITEREFWenzelTepperKorabFreitag2008" class="citation journal cs1">Wenzel, R. G.; Tepper, S; Korab, W. E.; Freitag, F (2008). "Serotonin syndrome risks when combining SSRI/SNRI drugs and triptans: is the FDA's alert warranted?". <i>Annals of Pharmacotherapy</i>. <b>42</b> (11): 1692–6. doi:<a href="javascript:if(confirm('https://doi.org/10.1345%2Faph.1L260  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1345%2Faph.1L260'" tppabs="https://doi.org/10.1345%2Faph.1L260" class="external text external">10.1345/aph.1L260</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18957623  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18957623'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18957623" class="external text external">18957623</a>.</cite></span></li><li id="cite_note-FDA_ALERT_[7/2006]:-26"> <span id="mw-reference-text-cite_note-FDA_ALERT_[7/2006]:-26" class="mw-reference-text"><cite id="CITEREFUS_Food_and_Drug_Administration2006" class="citation web cs1">US Food and Drug Administration (2006-07-19). <a href="javascript:if(confirm('https://web.archive.org/web/20080219184710/https://www.fda.gov/CDER/Drug/InfoSheets/HCP/venlafaxineHCP.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20080219184710/https://www.fda.gov/CDER/Drug/InfoSheets/HCP/venlafaxineHCP.htm'" tppabs="https://web.archive.org/web/20080219184710/https://www.fda.gov/CDER/Drug/InfoSheets/HCP/venlafaxineHCP.htm" class="external text external">"Information for Healthcare Professionals"</a>. Food and Drug Administration. Archived from <a href="javascript:if(confirm('https://www.fda.gov/CDER/Drug/InfoSheets/HCP/venlafaxineHCP.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/CDER/Drug/InfoSheets/HCP/venlafaxineHCP.htm'" tppabs="https://www.fda.gov/CDER/Drug/InfoSheets/HCP/venlafaxineHCP.htm" class="external text external">the original</a> on 2008-02-19<span class="reference-accessdate">. Retrieved <span class="nowrap">2008-01-10</span></span>.</cite></span></li><li id="cite_note-27"> <span id="mw-reference-text-cite_note-27" class="mw-reference-text"><cite id="CITEREFOrlovaRizzoliLoder2018" class="citation journal cs1">Orlova, Yulia; Rizzoli, Paul; Loder, Elizabeth (26 February 2018). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5885255  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5885255'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5885255" class="external text external">"Association of Coprescription of Triptan Antimigraine Drugs and Selective Serotonin Reuptake Inhibitor or Selective Norepinephrine Reuptake Inhibitor Antidepressants With Serotonin Syndrome"</a>. <i>JAMA Neurology</i>. <b>75</b> (5): 566–572. doi:<a href="javascript:if(confirm('https://doi.org/10.1001%2Fjamaneurol.2017.5144  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001%2Fjamaneurol.2017.5144'" tppabs="https://doi.org/10.1001%2Fjamaneurol.2017.5144" class="external text external">10.1001/jamaneurol.2017.5144</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5885255  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5885255'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5885255" class="external text external">5885255</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/29482205  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/29482205'" tppabs="https://pubmed.ncbi.nlm.nih.gov/29482205" class="external text external">29482205</a>.</cite></span></li><li id="cite_note-Tepper-28"> <span id="mw-reference-text-cite_note-Tepper-28" class="mw-reference-text"><cite id="CITEREFTepperRapoportSheftell2002" class="citation journal cs1">Tepper, S. J.; Rapoport, A. M.; Sheftell, F. D. (2002). <a href="javascript:if(confirm('https://doi.org/10.1001/archneur.59.7.1084  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001/archneur.59.7.1084'" tppabs="https://doi.org/10.1001/archneur.59.7.1084" class="external text external">"Mechanisms of action of the 5-HT1B/1D receptor agonists"</a>. <i>Archives of Neurology</i>. <b>59</b> (7): 1084–1088. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1001%2Farchneur.59.7.1084  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001%2Farchneur.59.7.1084'" tppabs="https://doi.org/10.1001%2Farchneur.59.7.1084" class="external text external">10.1001/archneur.59.7.1084</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12117355  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12117355'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12117355" class="external text external">12117355</a>.</cite></span></li><li id="cite_note-Hamel,_E._1999-29"> <span id="mw-reference-text-cite_note-Hamel,_E._1999-29" class="mw-reference-text"><cite id="CITEREFHamel,_E.1999" class="citation journal cs1">Hamel, E. (1999). <a href="javascript:if(confirm('https://doi.org/10.1017/s0317167100000123  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1017/s0317167100000123'" tppabs="https://doi.org/10.1017/s0317167100000123" class="external text external">"The biology of serotonin receptors: focus on migraine pathophysiology and treatment"</a>. <i>Can J Neurol Sci</i>. 26 Suppl 3 (3). 26 Suppl 3:S2–6. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1017%2Fs0317167100000123  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1017%2Fs0317167100000123'" tppabs="https://doi.org/10.1017%2Fs0317167100000123" class="external text external">10.1017/s0317167100000123</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10563226  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10563226'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10563226" class="external text external">10563226</a>.</cite></span></li><li id="cite_note-Lowther-30"> <span id="mw-reference-text-cite_note-Lowther-30" class="mw-reference-text"><cite id="CITEREFLowther,_S.1992" class="citation journal cs1">Lowther, S. (1992). "The distribution of 5HT<sub>1D</sub> and 5HT<sub>1E</sub> binding sites in human brain". <i>Eur J Pharmacol</i>. <b>222</b> (1): 137–42. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0014-2999%2892%2990473-h  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0014-2999%2892%2990473-h'" tppabs="https://doi.org/10.1016%2F0014-2999%2892%2990473-h" class="external text external">10.1016/0014-2999(92)90473-h</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1468490  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1468490'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1468490" class="external text external">1468490</a>.</cite></span></li><li id="cite_note-31"> <span id="mw-reference-text-cite_note-31" class="mw-reference-text"><cite id="CITEREFGoadsby1998" class="citation journal cs1">Goadsby, P. J. (1998). "Serotonin 5HT<sub>1B/1D</sub> receptor agonists in migraine - Comparative pharmacology and its therapeutic implications". <i>CNS Drugs</i>. <b>10</b> (4): 271–286. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00023210-199810040-00005  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00023210-199810040-00005'" tppabs="https://doi.org/10.2165%2F00023210-199810040-00005" class="external text external">10.2165/00023210-199810040-00005</a>.</cite></span></li><li id="cite_note-Bigal-32"> <span id="mw-reference-text-cite_note-Bigal-32" class="mw-reference-text"><cite id="CITEREFBigalBordiniAntoniazziSpeciali2003" class="citation journal cs1">Bigal, M. E.; Bordini, C. A.; Antoniazzi, A. L.; Speciali, J. G. (2003). <a href="javascript:if(confirm('https://doi.org/10.1590/s0004-282x2003000200032  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1590/s0004-282x2003000200032'" tppabs="https://doi.org/10.1590/s0004-282x2003000200032" class="external text external">"The triptan formulations: a critical evaluation"</a>. <i>Arquivos de Neuro-Psiquiatria</i>. <b>61</b> (2A): 313–320. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1590%2Fs0004-282x2003000200032  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1590%2Fs0004-282x2003000200032'" tppabs="https://doi.org/10.1590%2Fs0004-282x2003000200032" class="external text external">10.1590/s0004-282x2003000200032</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12806521  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12806521'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12806521" class="external text external">12806521</a>.</cite></span></li><li id="cite_note-Armstrong-33"> <span id="mw-reference-text-cite_note-Armstrong-33" class="mw-reference-text"><cite id="CITEREFArmstrongCozza2002" class="citation journal cs1">Armstrong, S. C.; Cozza, K. L. (2002). "Triptans". <i>Psychosomatics</i>. <b>43</b> (6): 502–504. doi:<a href="javascript:if(confirm('https://doi.org/10.1176%2Fappi.psy.43.6.502  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1176%2Fappi.psy.43.6.502'" tppabs="https://doi.org/10.1176%2Fappi.psy.43.6.502" class="external text external">10.1176/appi.psy.43.6.502</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12444236  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12444236'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12444236" class="external text external">12444236</a>.</cite></span></li><li id="cite_note-Mathew-34"> <span id="mw-reference-text-cite_note-Mathew-34" class="mw-reference-text"><cite id="CITEREFMathewLoder2005" class="citation journal cs1">Mathew, N. T.; Loder, E. W. (2005). "Evaluating the triptans". <i>The American Journal of Medicine Supplements</i>. <b>118</b> (1): 28–35. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.amjmed.2005.01.017  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.amjmed.2005.01.017'" tppabs="https://doi.org/10.1016%2Fj.amjmed.2005.01.017" class="external text external">10.1016/j.amjmed.2005.01.017</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15841885  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15841885'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15841885" class="external text external">15841885</a>.</cite></span></li><li id="cite_note-Deleu-35"> <span id="mw-reference-text-cite_note-Deleu-35" class="mw-reference-text"><cite class="citation journal cs1">Deleu, D.; Hanssens Y. (2000). <a href="javascript:if(confirm('https://semanticscholar.org/paper/b8bed329c760927665a775eadbcadd009e5caf8c  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://semanticscholar.org/paper/b8bed329c760927665a775eadbcadd009e5caf8c'" tppabs="https://semanticscholar.org/paper/b8bed329c760927665a775eadbcadd009e5caf8c" class="external text external">"Current and emerging second-generation triptans in acute migraine therapy: a comparative review"</a>. <i>J Clin Pharmacol</i>. <b>40</b> (7): 687–700. doi:<a href="javascript:if(confirm('https://doi.org/10.1177%2F00912700022009431  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1177%2F00912700022009431'" tppabs="https://doi.org/10.1177%2F00912700022009431" class="external text external">10.1177/00912700022009431</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10883409  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10883409'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10883409" class="external text external">10883409</a>.</cite><span class="cs1-maint citation-comment">CS1 maint: uses authors parameter (link)</span></span></li><li id="cite_note-36"> <span id="mw-reference-text-cite_note-36" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.astrazeneca.com/media-centre/press-releases/2017/astrazeneca-enters-agreement-with-grunenthal-to-divest-rights-to-migraine-treatment-zomig-07062017.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.astrazeneca.com/media-centre/press-releases/2017/astrazeneca-enters-agreement-with-grunenthal-to-divest-rights-to-migraine-treatment-zomig-07062017.html'" tppabs="https://www.astrazeneca.com/media-centre/press-releases/2017/astrazeneca-enters-agreement-with-grunenthal-to-divest-rights-to-migraine-treatment-zomig-07062017.html" class="external text external">"AstraZeneca enters agreement with Grünenthal to divest rights to migraine treatment Zomig"</a>. <i>www.astrazeneca.com</i>. <a href="javascript:if(confirm('https://web.archive.org/web/20180322204845/https://www.astrazeneca.com/media-centre/press-releases/2017/astrazeneca-enters-agreement-with-grunenthal-to-divest-rights-to-migraine-treatment-zomig-07062017.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20180322204845/https://www.astrazeneca.com/media-centre/press-releases/2017/astrazeneca-enters-agreement-with-grunenthal-to-divest-rights-to-migraine-treatment-zomig-07062017.html'" tppabs="https://web.archive.org/web/20180322204845/https://www.astrazeneca.com/media-centre/press-releases/2017/astrazeneca-enters-agreement-with-grunenthal-to-divest-rights-to-migraine-treatment-zomig-07062017.html" class="external text external">Archived</a> from the original on 2018-03-22<span class="reference-accessdate">. Retrieved <span class="nowrap">2018-03-22</span></span>.</cite></span></li><li id="cite_note-relpax_spc-37"> <span id="mw-reference-text-cite_note-relpax_spc-37" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://emc.medicines.org.uk/emc/assets/c/html/DisplayDoc.asp?DocumentID=8195  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://emc.medicines.org.uk/emc/assets/c/html/DisplayDoc.asp?DocumentID=8195'" tppabs="http://emc.medicines.org.uk/emc/assets/c/html/DisplayDoc.asp?DocumentID=8195" class="external text external">"Relpax – 20 mg and 40 mg"</a>. <a href="javascript:if(confirm('https://web.archive.org/web/20040620163458/http://emc.medicines.org.uk/emc/assets/c/html/displaydoc.asp?documentid=8195  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20040620163458/http://emc.medicines.org.uk/emc/assets/c/html/displaydoc.asp?documentid=8195'" tppabs="https://web.archive.org/web/20040620163458/http://emc.medicines.org.uk/emc/assets/c/html/displaydoc.asp?documentid=8195" class="external text external">Archived</a> from the original on 2004-06-20<span class="reference-accessdate">. Retrieved <span class="nowrap">2008-11-09</span></span>.</cite></span></li><li id="cite_note-Foyes-38"> <span id="mw-reference-text-cite_note-Foyes-38" class="mw-reference-text"><cite class="citation book cs1">Lippincott, W. W., Lemke, T. L., Williams, D. A., Roche, V. F., Zito, S. W. (2013). <i>Foye's Principles of Medicinal Chemistry</i>. Lippincott Williams &amp; Wilkins. pp.<span>&nbsp;</span>368–376.</cite><span class="cs1-maint citation-comment">CS1 maint: uses authors parameter (link)</span></span></li><li id="cite_note-39"> <span id="mw-reference-text-cite_note-39" class="mw-reference-text"><cite id="CITEREFHumphrey2007" class="citation journal cs1">Humphrey, P. P. (2007). "The discovery of a new drug class for the acute treatment of migraine". <i>Headache</i>. <b>47</b> (Suppl 1): S10–19. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1526-4610.2007.00672.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1526-4610.2007.00672.x'" tppabs="https://doi.org/10.1111%2Fj.1526-4610.2007.00672.x" class="external text external">10.1111/j.1526-4610.2007.00672.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17425704  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17425704'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17425704" class="external text external">17425704</a>.</cite></span></li><li id="cite_note-BBC_generic-40"> <span id="mw-reference-text-cite_note-BBC_generic-40" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://news.bbc.co.uk/1/hi/health/4996712.stm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://news.bbc.co.uk/1/hi/health/4996712.stm'" tppabs="http://news.bbc.co.uk/1/hi/health/4996712.stm" class="external text external">"Pharmacies to sell migraine drug"</a>. BBC NEWS. 2006-05-19. <a href="javascript:if(confirm('https://web.archive.org/web/20060924041401/http://news.bbc.co.uk/1/hi/health/4996712.stm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20060924041401/http://news.bbc.co.uk/1/hi/health/4996712.stm'" tppabs="https://web.archive.org/web/20060924041401/http://news.bbc.co.uk/1/hi/health/4996712.stm" class="external text external">Archived</a> from the original on 2006-09-24<span class="reference-accessdate">. Retrieved <span class="nowrap">2006-09-05</span></span>.</cite></span></li><li id="cite_note-41"> <span id="mw-reference-text-cite_note-41" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.avanir.com/press/avanir-pharmaceuticals-announces-fda-approval-onzetra%E2%84%A2-xsail%E2%84%A2-avp-825-acute-treatment-migraine  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.avanir.com/press/avanir-pharmaceuticals-announces-fda-approval-onzetra%E2%84%A2-xsail%E2%84%A2-avp-825-acute-treatment-migraine'" tppabs="http://www.avanir.com/press/avanir-pharmaceuticals-announces-fda-approval-onzetra%E2%84%A2-xsail%E2%84%A2-avp-825-acute-treatment-migraine" class="external text external">"Avanir's press release: FDA approves Onzetra"</a>. <i>Avanir Pharmaceuticals</i>. January 28, 2016. <a href="javascript:if(confirm('https://web.archive.org/web/20160511232617/http://www.avanir.com/press/avanir-pharmaceuticals-announces-fda-approval-onzetra%E2%84%A2-xsail%E2%84%A2-avp-825-acute-treatment-migraine  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20160511232617/http://www.avanir.com/press/avanir-pharmaceuticals-announces-fda-approval-onzetra%E2%84%A2-xsail%E2%84%A2-avp-825-acute-treatment-migraine'" tppabs="https://web.archive.org/web/20160511232617/http://www.avanir.com/press/avanir-pharmaceuticals-announces-fda-approval-onzetra%E2%84%A2-xsail%E2%84%A2-avp-825-acute-treatment-migraine" class="external text external">Archived</a> from the original on May 11, 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">May 20,</span> 2016</span>.</cite></span></li></ol></div>

<dl><dt>Sources</dt></dl>
<ul><li><cite id="CITEREFTepper_S._J.Rapoport_A._M.1999" class="citation journal cs1">Tepper S. J.; Rapoport A. M. (1999). "The triptans - A summary". <i>CNS Drugs</i>. <b>12</b> (5): 403–417. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00023210-199912050-00007  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00023210-199912050-00007'" tppabs="https://doi.org/10.2165%2F00023210-199912050-00007" class="external text external">10.2165/00023210-199912050-00007</a>.</cite></li></ul>
<p>

<br></p>
<div role="navigation" class="navbox" aria-labelledby="Antimigraine_preparations_(N02C)" style="padding:3px"><table class="nowraplinks hlist mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Antimigraine_preparations_(N02C)" style="font-size:114%;margin:0 4em">Antimigraine preparations (N02C)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Analgesic/abortive</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Serotonergics</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Ergolines</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Dihydroergotamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydroergotamine" title="Dihydroergotamine">Dihydroergotamine</a></li>
<li><a href="Ergotamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ergotamine" title="Ergotamine">Ergotamine</a></li>
<li><a href="Methysergide.htm" tppabs="https://ptable.com/wiki/compounds/A/Methysergide" title="Methysergide">Methysergide</a></li>
<li><a href="Lisuride.htm" tppabs="https://ptable.com/wiki/compounds/A/Lisuride" title="Lisuride">Lisuride</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">5-HT<sub>1</sub> agonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="Triptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Triptan" title="Triptan">Triptans</a></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Almotriptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Almotriptan" title="Almotriptan">Almotriptan</a></li>
<li>Avitriptan</li>
<li><a href="Eletriptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Eletriptan" title="Eletriptan">Eletriptan</a></li>
<li><a href="Frovatriptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Frovatriptan" title="Frovatriptan">Frovatriptan</a></li>
<li><a href="Naratriptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Naratriptan" title="Naratriptan">Naratriptan</a></li>
<li><a href="Rizatriptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Rizatriptan" title="Rizatriptan">Rizatriptan</a></li>
<li><a href="Sumatriptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Sumatriptan" title="Sumatriptan">Sumatriptan</a></li>
<li><a href="Zolmitriptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Zolmitriptan" title="Zolmitriptan">Zolmitriptan</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Ditans</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Alniditan<sup>§</sup></li>
<li>Lasmiditan</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Others</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Dimetotiazine</li>
<li>Dotarizine</li>
<li>Iprazochrome</li>
<li>Oxetorone</li>
<li>Pizotifen</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">CGRP-R antagonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Rimegepant</li>
<li>Ubrogepant</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Others</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Paracetamol.htm" tppabs="https://ptable.com/wiki/compounds/A/Paracetamol" title="Paracetamol">Paracetamol</a><sup>#</sup></li>
<li>Amidrine</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Prophylactic</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Calcium channel blockers</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Dotarizine</li>
<li>Lomerizine</li>
<li><a href="Verapamil.htm" tppabs="https://ptable.com/wiki/compounds/A/Verapamil" title="Verapamil">Verapamil</a></li>
<li><a href="Flunarizine.htm" tppabs="https://ptable.com/wiki/compounds/A/Flunarizine" title="Flunarizine">Flunarizine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Progestogens</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Flumedroxone acetate</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Sympatholytics</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Beta blockers
<ul><li><a href="Propranolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Propranolol" title="Propranolol">Propranolol</a><sup>#</sup></li>
<li><a href="Timolol.htm" tppabs="https://ptable.com/wiki/compounds/A/Timolol" title="Timolol">Timolol</a></li></ul></li>
<li><a href="Clonidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clonidine" title="Clonidine">Clonidine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Tricyclic antidepressants</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Amitriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Amitriptyline" title="Amitriptyline">Amitriptyline</a></li>
<li><a href="Nortriptyline.htm" tppabs="https://ptable.com/wiki/compounds/A/Nortriptyline" title="Nortriptyline">Nortriptyline</a></li>
<li><a href="Imipramine.htm" tppabs="https://ptable.com/wiki/compounds/A/Imipramine" title="Imipramine">Imipramine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Anticonvulsants</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Carbamazepine.htm" tppabs="https://ptable.com/wiki/compounds/A/Carbamazepine" title="Carbamazepine">Carbamazepine</a></li>
<li><a href="Oxcarbazepine.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxcarbazepine" title="Oxcarbazepine">Oxcarbazepine</a></li>
<li><a href="Topiramate.htm" tppabs="https://ptable.com/wiki/compounds/A/Topiramate" title="Topiramate">Topiramate</a></li>
<li>Valproate</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Anti-CGRP/CGRP-R mAbs</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Eptinezumab</li>
<li>Erenumab</li>
<li>Fremanezumab</li>
<li>Galcanezumab</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px"><div style="padding:0em 0.25em"><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div></div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Tryptamines" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Tryptamines" style="font-size:114%;margin:0 4em">Tryptamines</div></th></tr><tr><td colspan="2" class="navbox-list navbox-odd hlist" style="width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>1-Methylpsilocin</li>
<li>2,alpha-DMT</li>
<li>2-Me-DET</li>
<li>2-Methyl-5-HT</li>
<li>2,N,N-TMT</li>
<li>4,5-DHP-DMT</li>
<li>4,5-MDO-DMT</li>
<li>4,5-MDO-DiPT</li>
<li>4-AcO-DALT</li>
<li>4-AcO-DET</li>
<li>4-AcO-DMT</li>
<li>4-AcO-DiPT</li>
<li><span class="new">4-AcO-EPT</span></li>
<li><span class="new">4-AcO-NMT</span></li>
<li><span class="new">4-AcO-MALT</span></li>
<li>4-AcO-MET</li>
<li><span class="new">4-AcO-DPT</span></li>
<li>4-AcO-MiPT</li>
<li>4-Hydroxy-5-methoxydimethyltryptamine</li>
<li><span class="new">4-HO-DALT</span></li>
<li>4-HO-DBT</li>
<li>4-HO-DET</li>
<li>4-HO-DiPT</li>
<li>4-HO-DPT</li>
<li>4-HO-DSBT</li>
<li>4-HO-EPT</li>
<li><span class="new">4-HO-MALT</span></li>
<li>4-HO-MET</li>
<li>4-HO-McPT</li>
<li>4-HO-McPeT</li>
<li>4-HO-MiPT</li>
<li>4-HO-MPMI</li>
<li>4-HO-MPT</li>
<li><span class="new">4-HO-NMT</span></li>
<li>4-HO-pyr-T</li>
<li>4-HO-αMT</li>
<li>4-Me-αET</li>
<li>4-Me-αMT</li>
<li><span class="new">4-MeO-DiPT</span></li>
<li>4-MeO-DMT</li>
<li>4-MeO-MiPT</li>
<li>5,6-MeO-MiPT</li>
<li>5,6-MDO-DiPT</li>
<li>5,6-MDO-DMT</li>
<li>5,6-MDO-MiPT</li>
<li>5,7-Dihydroxytryptamine</li>
<li>5-BT</li>
<li>5-Bromo-DMT</li>
<li>5-CT</li>
<li>5-Chloro-αMT</li>
<li><span class="new">5-Ethoxy-αMT</span></li>
<li>5-Ethoxy-DMT</li>
<li>5-Ethyl-DMT</li>
<li>5-Fluoro-αMT</li>
<li>5-Fluoro-DMT</li>
<li>5-HO-αMT</li>
<li>5-HO-DiPT</li>
<li><a href="5-Hydroxytryptophan.htm" tppabs="https://ptable.com/wiki/compounds/A/5-Hydroxytryptophan" title="5-Hydroxytryptophan">5-HTP</a></li>
<li>5-MeS-DMT</li>
<li><a href="5-Methoxytryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/5-Methoxytryptamine" title="5-Methoxytryptamine">5-Methoxytryptamine</a></li>
<li>5-MeO-7,N,N-TMT</li>
<li><span class="new">5-Methyl-αET</span></li>
<li>5-MeO-2-TMT</li>
<li>5-MeO-αET </li>
<li>5-MeO-αMT</li>
<li>5-MeO-DALT</li>
<li>5-MeO-DET</li>
<li>5-MeO-DiPT</li>
<li><a href="5-MeO-DMT.htm" tppabs="https://ptable.com/wiki/compounds/A/5-MeO-DMT" title="5-MeO-DMT">5-MeO-DMT</a></li>
<li>5-MeO-DPT</li>
<li>5-MeO-EiPT</li>
<li>5-MeO-EPT</li>
<li>5-MeO-MALT</li>
<li>5-MeO-MiPT</li>
<li>5-MeO-MPMI</li>
<li>5-MeO-NMT</li>
<li>5-MeO-pyr-T</li>
<li>5-MeO-NBpBrT</li>
<li>5-Methyl-DMT</li>
<li>5-(Nonyloxy)tryptamine</li>
<li>6-Fluoro-αMT</li>
<li>6-Hydroxymelatonin</li>
<li>6-MeO-THH</li>
<li>7-Methyl-α-ethyltryptamine</li>
<li>7-Methyl-DMT</li>
<li>Acetryptine</li>
<li>Aeruginascin</li>
<li><a href="Alpha-Ethyltryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Alpha-Ethyltryptamine" title="Alpha-Ethyltryptamine">αET</a></li>
<li>Alpha,N-DMT</li>
<li>α,N,N-Trimethyltryptamine</li>
<li>Alpha,N,O-TMS</li>
<li>AL-37350A</li>
<li><a href="Alpha-Methyltryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Alpha-Methyltryptamine" title="Alpha-Methyltryptamine">αMT</a></li>
<li>Baeocystin</li>
<li>BNC-210</li>
<li>Bufotenidine</li>
<li><a href="Bufotenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Bufotenin" title="Bufotenin">Bufotenin (5-HO-DMT)</a></li>
<li>BW-723C86</li>
<li>Convolutindole A</li>
<li>CP-132,484</li>
<li>DALT</li>
<li>DBT</li>
<li>Desformylflustrabromine</li>
<li><a href="Diethyltryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Diethyltryptamine" title="Diethyltryptamine">DET</a></li>
<li>DiPT</li>
<li>DPT</li>
<li>E-6801</li>
<li>E-6837</li>
<li>Ethocybin</li>
<li>EiPT</li>
<li>EMDT</li>
<li>EPT</li>
<li>FGIN-127</li>
<li>FGIN-143</li>
<li><a href="Harmaline.htm" tppabs="https://ptable.com/wiki/compounds/A/Harmaline" title="Harmaline">Harmaline</a></li>
<li>HIOC</li>
<li>Ibogaine</li>
<li>Idalopirdine</li>
<li>Indorenate</li>
<li>Iprocin</li>
<li>Lespedamine</li>
<li>Luzindole</li>
<li>MET</li>
<li>Methylbutyltryptamine</li>
<li>MiPT</li>
<li>MPT</li>
<li>Miprocin</li>
<li><a href="Melatonin.htm" tppabs="https://ptable.com/wiki/compounds/A/Melatonin" title="Melatonin">Melatonin</a></li>
<li>MS-245</li>
<li><a href="N-Acetylserotonin.htm" tppabs="https://ptable.com/wiki/compounds/A/N-Acetylserotonin" title="N-Acetylserotonin">NAS</a></li>
<li>N-Ethyltryptamine</li>
<li>N-Feruloylserotonin</li>
<li><a href="N-Methyltryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/N-Methyltryptamine" title="N-Methyltryptamine">NMT</a></li>
<li>DMT</li>
<li>Norbaeocystin</li>
<li><a href="N-Acetylserotonin.htm" tppabs="https://ptable.com/wiki/compounds/A/N-Acetylserotonin" title="N-Acetylserotonin">Normelatonin</a></li>
<li>O-4310</li>
<li>Oxypertine</li>
<li>Plakohypaphorine</li>
<li>PiPT</li>
<li><a href="Psilocin.htm" tppabs="https://ptable.com/wiki/compounds/A/Psilocin" title="Psilocin">Psilocin (4-HO-DMT)</a></li>
<li>Psilocybin (4-PO-DMT)</li>
<li>Pyr-T</li>
<li><a href="Rizatriptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Rizatriptan" title="Rizatriptan">Rizatriptan</a></li>
<li>RU-28306</li>
<li><a href="Serotonin.htm" tppabs="https://ptable.com/wiki/compounds/A/Serotonin" title="Serotonin">Serotonin</a></li>
<li>ST-1936</li>
<li><a href="Sumatriptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Sumatriptan" title="Sumatriptan">Sumatriptan</a></li>
<li><a href="Tryptamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tryptamine" title="Tryptamine">Tryptamine</a></li>
<li><a href="Tryptophan.htm" tppabs="https://ptable.com/wiki/compounds/A/Tryptophan" title="Tryptophan">Tryptophan</a></li>
<li><a href="Yohimbine.htm" tppabs="https://ptable.com/wiki/compounds/A/Yohimbine" title="Yohimbine">Yohimbine</a></li>
<li>Yuremamine</li>
<li><a href="Zolmitriptan.htm" tppabs="https://ptable.com/wiki/compounds/A/Zolmitriptan" title="Zolmitriptan">Zolmitriptan</a></li></ul>
</div></td></tr></tbody></table></div>


<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details><!--htdig_noindex--><div><div style="clear:both; background-image:linear-gradient(180deg, #E8E8E8, white); border-top: dashed 2px #AAAAAA; padding: 0.5em 0.5em 0.5em 0.5em; margin-top: 1em; direction: ltr;">
    This article is issued from <a class="external text" title="Last edited on 2020-06-24" href="javascript:if(confirm('https://en.wikipedia.org/wiki/?title=Triptan&oldid=964276904  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/wiki/?title=Triptan&oldid=964276904'" tppabs="https://en.wikipedia.org/wiki/?title=Triptan&oldid=964276904">Wikipedia</a>. The text is licensed under <a class="external text" href="javascript:if(confirm('https://creativecommons.org/licenses/by-sa/4.0/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://creativecommons.org/licenses/by-sa/4.0/'" tppabs="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons - Attribution - Sharealike</a>. Additional terms may apply for the media files.
</div>
</div><!--/htdig_noindex--></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>